[Batlle M] Department of Surgery, Hospital General Granollers, Universitat Autònoma de Barcelona, Barcelona, Spain. [Badia JM] Department of Surgery, Hospital General Granollers, Universitat Internacional de Catalunya, Barcelona, Spain. [Hernández S] VINCat Programme Surveillance of Healthcare Related Infections in Catalonia, Departament de Salut, Barcelona, Spain. [Grau S] Pharmacy Department, Infectious Diseases Service, Infectious Pathology and Antimicriobials Group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Hospital del Mar, Barcelona, Spain. [Padulles A] Pharmacy Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain. CIBER de Enfermedades Infecciosas (CIBERINFEC), ISC III, Madrid, Spain. [Boix-Palop L] Infectious Diseases Service, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain
Hospital General de Granollers
2024-03-05T07:39:17Z
2024-03-05T07:39:17Z
2023-11
Anti-Bacterial Agents; Surgical Wound Infection; Infection Control
Agentes Antibacterianos; Infección de Heridas Quirúrgicas; Control de la infección
Agents antibacterians; Infecció de la ferida quirúrgica; Control de la infecció
Background: Guidelines recommend 5-7 days of antibiotic treatment in patients with surgical infection and adequate source control. This nationwide stewardship intervention aimed to reduce the duration of treatments in surgical patients to <7 days. Methods: Prospective cohort study evaluating surgical patients receiving antibiotics ≥7 days in 32 hospitals. Indication for treatment, quality of source control, type of recommendations issued, and adherence to the recommendations were analysed. Temporal trends in the percentages of patients with treatment >7 days were evaluated using a linear regression model and Pearson's correlation coefficients. Results: A total of 32 499 patients were included. Of these, 13.7% had treatments ≥7 days. In all, 3912 stewardship interventions were performed, primarily in general surgery (90.7%) and urology (8.1%). The main types of infection were intra-abdominal (73.4%), skin/soft tissues (9.8%) and urinary (9.2%). The septic focus was considered controlled in 59.9% of cases. Out of 5458 antibiotic prescriptions, the most frequently analysed drugs were piperacillin/tazobactam (21.7%), metronidazole (11.2%), amoxicillin/clavulanate (10.3%), meropenem (10.7%), ceftriaxone (9.3%) and ciprofloxacin (6.7%). The main recommendations issued were: treatment discontinuation (35.0%), maintenance (40.0%) or de-escalation (15.5%), and the overall adherence rate was 91.5%. With adequate source control, the most frequent recommendation was to terminate treatment (51.2%). Throughout the study period, a significant decrease in the percentage of prolonged treatments was observed (Pc=-0.69;P < 0.001). Conclusions: This stewardship programme reduced the duration of treatments in surgical departments. Preference was given to general surgery services, intra-abdominal infection, and beta-lactam antibiotics, including carbapenems. Adherence to the issued recommendations was high.
Article
Published version
English
Medicaments antibacterians; Sales d'operacions; Infeccions quirúrgiques; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents; DISEASES::Bacterial Infections and Mycoses::Infection::Wound Infection::Surgical Wound Infection; HEALTH CARE::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos; ENFERMEDADES::infecciones bacterianas y micosis::infección::infección de heridas::infección de la herida quirúrgica; ATENCIÓN DE SALUD::ambiente y salud pública::salud pública::práctica de la salud pública::control de enfermedades transmisibles::control de infecciones
Elsevier
International Journal of Antimicrobial Agents;62(5)
https://doi.org/10.1016/j.ijantimicag.2023.106943
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/